Skip to content
Home
Docs
Parameter
Laboratory Tests
The Bleeding Time (BT)
The Bleeding Time (BT)
Related items
Analytical Information :
6
Pre-Analytical Issues in Platelet Function Testing - An Update
Minimum citrate tube fill volume for routine coagulation testing
Pre-Analytical Issues in Platelet Function Testing - An Update
Update on platelet aggregation testing
Comparison of two statistical software programs for determining reference intervals of screening coagulation assays
Analytical performance specifications for hemostasis parameters
Cases :
9
Acquired von Willebrand disease and marginal zone lymphoma
Hermansky-Pudlak syndrome
Hermansky Pudlak syndrome
Von Willebrand Jürgens syndrome type I, case study 2016
Acquired Glanzmann’s thrombasthenia
Von Willebrand Jürgens syndrome type I, case study 2019
Dysfibrinogenemia, case study
Von Willebrand Disease type 2B, case study
Von Willebrand Disease type 1, case study
ECAT Documents :
40
Von Willebrand Factor (VWF)
Thrombus (plural form is Thrombi)
Platelet
Phospholipids
Hypofibrinogenemia
Fibrinogen (FI) and Fibrinogen Assay
Fibrin
Dysfibrinogenemia
Desmopressin Acetate (DDAVP)
Common Pathway of Coagulation
Coagulation Factors
Coagulation Cascade
Clot (Blood Clot)
Differential sensitivity of von Willebrand factor activity assays to reduced VWF molecular weight forms: A large international cross-laboratory study
Update on diagnostic testing for platelet function disorders: What is practical and useful?
The results of the workshop on inhibitor testing
Results of the workshop on platelet function testing
The laboratory diagnosis of vWD: current insights
Case studies in Bleeding disorders
The results of fibrinolytic surveys
First experience of ECAT with Measurement of New Oral Anticoagulation Drugs
Factor VIII inhibitor testing – a way to comparable test results
ADAMTS13 and the pathogenesis of Thrombotic Thrombocytopenic Purpura (TTP)
Bleeding webinar 2021, von Willebrand
The relevance of pre-operative hemostasis screening
The differential diagnosis between TTP and atypical HUS
The diagnosis of von Willebrand Disease
The role of contact activation in thrombosis and beyond
Developmental haemostasis: consequences for clinical practice
Platelet Function Testing
The use of snake venoms in the coagulation laboratory
What information does the doctor expect from the laboratory? What kind of services can a laboratory deliver to the physician?
Low von Willebrand Factor and diagnostic treshold
Thrombogenomics
When Haemostasis Assays Mislead
Impact of COVID-19 pandemic on the quality of test output in haemostasis laboratories
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey
Diagnosis of von Willebrand disease: An assessment of the quality of testing in North American laboratories
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade
Systematic review and meta-analysis of within-subject and between-subject biological variation data of coagulation and fibrinolytic measurands
Guidelines :
1
Recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders, ICSH recommendations
Haemostatic Cascade :
5
TF Pathway (Extrinsic) with Common Pathway (PT)
Intrinsic Pathway APTT
Fibrinolytic Pathway
Coagulation Pathways (All Components)
Activation of TAFI by Thrombin
Quality Issues :
4
Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance Specifications
Wet Workshop on Platelet Function Testing
External quality assessment / proficiency testing for platelet function disorders
External quality assessment for von Willebrand Factor laboratory analysis
Questions or suggestions?
Clotpedia Support Form
Submit
Success
